Imsidolimab (ANB 019) is a high-affinity, humanized monoclonal antibody of anti-IL-36R. Imsidolimab antagonizes IL-36 cytokine signal transduction. Imsidolimab has potential application in generalized pustular psoriasis (GPP) and other inflammatory skin diseases.
Purity:
>95.0%
CAS Number:
[2102543-86-0]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted
